# ATORVASTATIN CALCIUM
> **ANDA216848** · Abbreviated New Drug Application (Generic) · Sponsor: LEPU PHARM · Approved 2022-11-03
## Drug
- **FDA Application Number:** ANDA216848
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ATORVASTATIN CALCIUM
- **Generic name:** ATORVASTATIN CALCIUM
- **Active ingredients:** ATORVASTATIN CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LEPU PHARM
- **Manufacturer:** Lepu Pharmaceutical Technology Co., Ltd.
- **First approval:** 2022-11-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216848)
---
*AI Analytics · CC0 1.0*